Research Excellence Framework 2021 (REF 2021) 

In our first independent REF submission, LSTM was recognised for the outstanding impact of our research, ranking 2nd in the UK across all disciplines.

According to Times Higher Education, our overall GPA placed us 12th out of 157 institutions nationally.

With joint 6th place in clinical medicine, we are ranked amongst some of the major research institutions in the UK, with a combined score of 60% in the outstanding category and 32% in the international excellence category.

“I am delighted to see this high ranking which is not only a consequence of the excellent impact of our work but is also underpinned by nearly 50% of our publications scoring 4 * in our A1 submission” said LSTM’s Vice-Chancellor, Professor David Lalloo. ‘This shows that LSTM can deliver excellent research whilst maintaining a strong focus on research translation and uptake. This underpins our long-term mission of producing innovative science and translating it into interventions with real benefits for health among some of the world’s poorest populations.”

We also had a very strong return in our second, smaller, submission to ‘Public Health, Health Services and Primary Care (A2)’. All of our Impact Case Studies, and nearly 80% of our publications in this submission were judged as internationally excellent.

With LSTM returning 100% of eligible staff, including staff in seven countries in Africa and Asia, the results are a reflection of the impact of the work undertaken across the institution as well as within numerous partnerships across the world. The research in both submissions was greatly facilitated by long-standing partnerships with industry, the NHS in the UK, as well NGOs, Governments, Ministries of Health and academic partners across the world.